Last updated on July 2019

Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy


Brief description of study

This random, open, control and multicenter clinical trial mainly aims to assess the urine protein remission rate of tacrolimus (TAC) monotherapy for idiopathic membranous nephropathy (IMN).

Clinical Study Identifier: NCT03864250

Find a site near you

Start Over